{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T20:48:26Z","timestamp":1794689306765,"version":"4.9.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007194","name":"Wenzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["ZY2020025"],"award-info":[{"award-number":["ZY2020025"]}],"id":[{"id":"10.13039\/501100007194","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03270-3","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:25:32Z","timestamp":1761121532000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Bruceine D inhibits hepatocellular carcinoma by regulating the STAT3 signaling pathway through HSP70"],"prefix":"10.1186","volume":"30","author":[{"given":"Pu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanyun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengguang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"issue":"5","key":"3270_CR1","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.annonc.2025.02.006","volume":"36","author":"A Vogel","year":"2025","unstructured":"Vogel A, et al. Hepatocellular carcinoma: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2025;36(5):491\u2013506.","journal-title":"Ann Oncol"},{"key":"3270_CR2","first-page":"145","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70:145\u201364.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"3270_CR3","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00268-006-0359-z","volume":"31","author":"YB Cho","year":"2007","unstructured":"Cho YB, et al. Outcomes of hepatic resection for a single large hepatocellular carcinoma. World J Surg. 2007;31(4):795\u2013801.","journal-title":"World J Surg"},{"issue":"4","key":"3270_CR4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3390\/diagnostics6040044","volume":"6","author":"J von Felden","year":"2016","unstructured":"von Felden J, et al. First- and second-line targeted systemic therapy in hepatocellular carcinoma-an update on patient selection and response evaluation. Diagnostics. 2016;6(4):44.","journal-title":"Diagnostics"},{"key":"3270_CR5","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the L. EASL Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182\u2013236.","DOI":"10.1016\/j.jhep.2018.03.019"},{"issue":"9822","key":"3270_CR6","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","volume":"379","author":"A Forner","year":"2012","unstructured":"Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012;379(9822):1245\u201355.","journal-title":"Lancet"},{"issue":"1","key":"3270_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41392-020-0187-x","volume":"5","author":"W Tang","year":"2020","unstructured":"Tang W, et al. The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects. Signal Transduct Target Ther. 2020;5(1):87.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"3270_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41392-024-02075-w","volume":"10","author":"J Zheng","year":"2025","unstructured":"Zheng J, et al. Hepatocellular carcinoma: signaling pathways and therapeutic advances. Signal Transduct Target Ther. 2025;10(1):35.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"3270_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.5009\/gnl.2014.8.1.79","volume":"8","author":"GH Kang","year":"2014","unstructured":"Kang GH, et al. Prognostic significance of p53, mTOR, c-Met, IGF-1R, and HSP70 overexpression after the resection of hepatocellular carcinoma. Gut Liver. 2014;8(1):79\u201387.","journal-title":"Gut Liver"},{"issue":"4","key":"3270_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.tibs.2018.02.003","volume":"43","author":"NB Nillegoda","year":"2018","unstructured":"Nillegoda NB, Wentink AS, Bukau B. Protein disaggregation in multicellular organisms. Trends Biochem Sci. 2018;43(4):285\u2013300.","journal-title":"Trends Biochem Sci"},{"key":"3270_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12915-017-0474-3","volume":"16","author":"EA Craig","year":"2018","unstructured":"Craig EA. Hsp70 at the membrane: driving protein translocation. BMC Biol. 2018;16:11.","journal-title":"BMC Biol"},{"issue":"1289","key":"3270_CR12","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1098\/rstb.1993.0031","volume":"339","author":"WJ Welch","year":"1993","unstructured":"Welch WJ. Heat shock proteins functioning as molecular chaperones: their roles in normal and stressed cells. Philos Trans R Soc Lond B Biol Sci. 1993;339(1289):327\u201333.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"3270_CR13","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1479-5876-10-96","volume":"10","author":"MB Cai","year":"2012","unstructured":"Cai MB, et al. Expression of heat shock protein 70 in nasopharyngeal carcinomas: different expression patterns correlate with distinct clinical prognosis. J Transl Med. 2012;10:96.","journal-title":"J Transl Med"},{"key":"3270_CR14","first-page":"35","volume":"212","author":"XP Wang","year":"2010","unstructured":"Wang XP, Wang QX, Lin HP. Correlation between clinicopathology and expression of heat shock protein 72 and glycoprotein 96 in human esophageal squamous cell carcinoma. Clin Dev Immunol. 2010;212:35\u201341.","journal-title":"Clin Dev Immunol"},{"issue":"3","key":"3270_CR15","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.pharmthera.2012.08.014","volume":"136","author":"T Liu","year":"2012","unstructured":"Liu T, Daniels CK, Cao SS. Comprehensive review on the HSC70 functions, interactions with related molecules and involvement in clinical diseases and therapeutic potential. Pharmacol Ther. 2012;136(3):354\u201374.","journal-title":"Pharmacol Ther"},{"issue":"3","key":"3270_CR16","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.3892\/ol.2016.5551","volume":"13","author":"Z Yi","year":"2017","unstructured":"Yi Z, et al. Extracellular HSP70\/HSP70-PCs regulate hepatocarcinoma cell migration and invasion via RhoA. Oncol Lett. 2017;13(3):1095\u2013100.","journal-title":"Oncol Lett"},{"key":"3270_CR17","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.12659\/MSM.895592","volume":"21","author":"Z Wang","year":"2015","unstructured":"Wang Z, et al. Expression of P53 and HSP70 in chronic hepatitis, liver cirrhosis, and early and advanced hepatocellular carcinoma tissues and their diagnostic value in hepatocellular carcinoma: an immunohistochemical study. Med Sci Monit. 2015;21:3209\u201315.","journal-title":"Med Sci Monit"},{"issue":"9","key":"3270_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e05002","volume":"6","author":"K Kobayashi","year":"2020","unstructured":"Kobayashi K, et al. Heat shock protein 70 positively regulates transforming growth factor-alpha-induced hepatocellular carcinoma cell migration via the AKT signaling pathway. Heliyon. 2020;6(9):e05002.","journal-title":"Heliyon"},{"issue":"3","key":"3270_CR19","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41416-020-01135-6","volume":"124","author":"LH Yang","year":"2021","unstructured":"Yang LH, et al. Acetyl-bufalin shows potent efficacy against non-small-cell lung cancer by targeting the CDK9\/STAT3 signalling pathway. Br J Cancer. 2021;124(3):645\u201357.","journal-title":"Br J Cancer"},{"issue":"11","key":"3270_CR20","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/nrc3818","volume":"14","author":"H Yu","year":"2014","unstructured":"Yu H, et al. Revisiting STAT3 signalling in cancer: new and unexpected biological functions. Nat Rev Cancer. 2014;14(11):736\u201346.","journal-title":"Nat Rev Cancer"},{"key":"3270_CR21","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.3389\/fonc.2020.01120","volume":"10","author":"X Wang","year":"2020","unstructured":"Wang X, et al. STAT3 contributes to radioresistance in cancer. Front Oncol. 2020;10:1120.","journal-title":"Front Oncol"},{"key":"3270_CR22","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ejphar.2018.07.034","volume":"834","author":"YT Lee","year":"2018","unstructured":"Lee YT, Tan YJ, Oon CE. Molecular targeted therapy: treating cancer with specificity. Eur J Pharmacol. 2018;834:188\u201396.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"3270_CR23","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41419-020-2317-3","volume":"11","author":"JJ Fan","year":"2020","unstructured":"Fan JJ, et al. Bruceine D induces lung cancer cell apoptosis and autophagy via the ROS\/MAPK signaling pathway in vitro and in vivo. Cell Death Dis. 2020;11(2):126.","journal-title":"Cell Death Dis"},{"issue":"47","key":"3270_CR24","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000023197","volume":"99","author":"DD Luo","year":"2020","unstructured":"Luo DD, et al. Efficacy and safety of Brucea javanica oil emulsion for liver cancer a protocol for systematic review and meta-analysis. Medicine. 2020;99(47):e23197.","journal-title":"Medicine"},{"key":"3270_CR25","doi-asserted-by":"publisher","first-page":"5928562","DOI":"10.1155\/2016\/5928562","volume":"2016","author":"W Xu","year":"2016","unstructured":"Xu W, et al. The efficacy of Brucea javanica oil emulsion injection as adjunctive therapy for advanced non-small-cell lung cancer: a meta-analysis. Evid Based Compl Altern Med. 2016;2016:5928562.","journal-title":"Evid Based Compl Altern Med"},{"issue":"6","key":"3270_CR26","first-page":"2015","volume":"44","author":"JH Xie","year":"2019","unstructured":"Xie JH, et al. Apoptosis induced by bruceine D in human non-small-cell lung cancer cells involves mitochondrial ROS-mediated death signaling. Int J Mol Med. 2019;44(6):2015\u201326.","journal-title":"Int J Mol Med"},{"key":"3270_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109089","volume":"117","author":"B Tan","year":"2019","unstructured":"Tan B, et al. Bruceine D induces apoptosis in human non-small cell lung cancer cells through regulating JNK pathway. Biomed Pharmacother. 2019;117:109089.","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"3270_CR28","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1016\/j.apsb.2021.05.009","volume":"11","author":"R Huang","year":"2021","unstructured":"Huang R, et al. Bruceine D inhibits HIF-1alpha-mediated glucose metabolism in hepatocellular carcinoma by blocking ICAT\/beta-catenin interaction. Acta Pharm Sin B. 2021;11(11):3481\u201392.","journal-title":"Acta Pharm Sin B"},{"key":"3270_CR29","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.canlet.2017.06.014","volume":"403","author":"Z Cheng","year":"2017","unstructured":"Cheng Z, et al. Bruceine D inhibits hepatocellular carcinoma growth by targeting beta-catenin\/jagged1 pathways. Cancer Lett. 2017;403:195\u2013205.","journal-title":"Cancer Lett"},{"issue":"2","key":"3270_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ph15020179","volume":"15","author":"C Cipriani","year":"2022","unstructured":"Cipriani C, et al. Bruceine D identified as a drug candidate against breast cancer by a novel drug selection pipeline and cell viability assay. Pharmaceuticals (Basel). 2022;15(2):179.","journal-title":"Pharmaceuticals (Basel)"},{"key":"3270_CR31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jare.2023.05.012","volume":"58","author":"W Tang","year":"2023","unstructured":"Tang W, et al. Targeting Trop2 by Bruceine D suppresses breast cancer metastasis by blocking Trop2\/beta-catenin positive feedback loop. J Adv Res. 2023;58:193\u2013210.","journal-title":"J Adv Res"},{"key":"3270_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.584960","volume":"11","author":"L Li","year":"2020","unstructured":"Li L, et al. Bruceine D inhibits cell proliferation through downregulating LINC01667\/microRNA-138-5p\/cyclin E1 axis in gastric cancer. Front Pharmacol. 2020;11:584960.","journal-title":"Front Pharmacol"},{"issue":"1","key":"3270_CR33","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.canlet.2009.02.017","volume":"281","author":"ST Lau","year":"2009","unstructured":"Lau ST, et al. Bruceine D induces apoptosis in pancreatic adenocarcinoma cell line PANC-1 through the activation of p38-mitogen activated protein kinase. Cancer Lett. 2009;281(1):42\u201352.","journal-title":"Cancer Lett"},{"key":"3270_CR34","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ejphar.2014.02.002","volume":"728","author":"Z Xiao","year":"2014","unstructured":"Xiao Z, et al. Role of microrna-95 in the anticancer activity of Brucein D in hepatocellular carcinoma. Eur J Pharmacol. 2014;728:141\u201350.","journal-title":"Eur J Pharmacol"},{"issue":"17","key":"3270_CR35","doi-asserted-by":"publisher","first-page":"7345","DOI":"10.1002\/cam4.2612","volume":"8","author":"S Wang","year":"2019","unstructured":"Wang S, et al. Bruceine D inhibits tumor growth and stem cell-like traits of osteosarcoma through inhibition of STAT3 signaling pathway. Cancer Med. 2019;8(17):7345\u201358.","journal-title":"Cancer Med"},{"key":"3270_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.177994","volume":"1003","author":"J Ma","year":"2025","unstructured":"Ma J, et al. Bruceine D inhibits CAF-promoted angiogenesis of breast cancer via suppressing IL-6-mediated activation of the STAT3\/Notch1\/VEGFR2 axis. Eur J Pharmacol. 2025;1003:177994.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"3270_CR37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27\u201330.","journal-title":"Nucleic Acids Res"},{"key":"3270_CR38","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.biopha.2018.06.065","volume":"105","author":"R Ye","year":"2018","unstructured":"Ye R, et al. Comprehensive anti-tumor effect of Brusatol through inhibition of cell viability and promotion of apoptosis caused by autophagy via the PI3K\/Akt\/mTOR pathway in hepatocellular carcinoma. Biomed Pharmacother. 2018;105:962\u201373.","journal-title":"Biomed Pharmacother"},{"key":"3270_CR39","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jare.2020.07.004","volume":"26","author":"JH Lee","year":"2020","unstructured":"Lee JH, et al. Brusatol suppresses STAT3-driven metastasis by downregulating epithelial-mesenchymal transition in hepatocellular carcinoma. J Adv Res. 2020;26:83\u201394.","journal-title":"J Adv Res"},{"issue":"5","key":"3270_CR40","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1101\/gad.305405","volume":"19","author":"M Rohde","year":"2005","unstructured":"Rohde M, et al. Members of the heat-shock protein 70 family promote cancer cell growth by distinct mechanisms. Genes Dev. 2005;19(5):570\u201382.","journal-title":"Genes Dev"},{"issue":"2","key":"3270_CR41","first-page":"457","volume":"120","author":"F Chalmin","year":"2010","unstructured":"Chalmin F, et al. Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. J Clin Invest. 2010;120(2):457\u201371.","journal-title":"J Clin Invest"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03270-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03270-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03270-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:25:35Z","timestamp":1761121535000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-03270-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3270"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03270-3","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"13 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human HCC tissues and matched adjacent non-tumor tissues (n\u2009=\u200911 pairs) were collected with approval from the Institutional Ethics Committee of First Affiliated Hospital of Wenzhou Medical University (Approval No. 2020023), and written informed consent was obtained from all participants prior to sample collection. All animal experiments were conducted in accordance with the institutional guidelines for laboratory animal care and were approved by the Committee of Wenzhou Medical University Animal Policy and Welfare Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1010"}}